Maurizi A - Search Results

1

Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine.

Paganini C, Gramegna Tota C, Monti L, Monti I, Maurizi A, Capulli M, Bourmaud M, Teti A, Cohen-Solal M, Villani S, Forlino A, Superti-Furga A, Rossi A. Paganini C, et al. Among authors: maurizi a. Biochem Pharmacol. 2021 Mar;185:114452. doi: 10.1016/j.bcp.2021.114452. Epub 2021 Feb 3. Biochem Pharmacol. 2021. PMID: 33545117

2

Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models.

Alam I, Gray AK, Chu K, Ichikawa S, Mohammad KS, Capannolo M, Capulli M, Maurizi A, Muraca M, Teti A, Econs MJ, Del Fattore A. Alam I, et al. Among authors: maurizi a. Bone. 2014 Feb;59:66-75. doi: 10.1016/j.bone.2013.10.021. Epub 2013 Nov 1. Bone. 2014. PMID: 24185277 Free PMC article.

3

The Great Beauty of the osteoclast.

Cappariello A, Maurizi A, Veeriah V, Teti A. Cappariello A, et al. Among authors: maurizi a. Arch Biochem Biophys. 2014 Sep 15;558:70-8. doi: 10.1016/j.abb.2014.06.017. Epub 2014 Jun 27. Arch Biochem Biophys. 2014. PMID: 24976175 Review.

4

Reprint of: The Great Beauty of the osteoclast.

Cappariello A, Maurizi A, Veeriah V, Teti A. Cappariello A, et al. Among authors: maurizi a. Arch Biochem Biophys. 2014 Nov 1;561:13-21. doi: 10.1016/j.abb.2014.08.009. Arch Biochem Biophys. 2014. PMID: 25282390 Review.

5

Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation.

Cappariello A, Paone R, Maurizi A, Capulli M, Rucci N, Muraca M, Teti A. Cappariello A, et al. Among authors: maurizi a. Biomaterials. 2015 Apr;46:58-69. doi: 10.1016/j.biomaterials.2014.12.033. Epub 2015 Jan 17. Biomaterials. 2015. PMID: 25678116 Free PMC article.

6

Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2.

Capulli M, Maurizi A, Ventura L, Rucci N, Teti A. Capulli M, et al. Among authors: maurizi a. Mol Ther Nucleic Acids. 2015 Sep 1;4(9):e248. doi: 10.1038/mtna.2015.21. Mol Ther Nucleic Acids. 2015. PMID: 26325626 Free PMC article.

7

Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate.

Thaler R, Maurizi A, Roschger P, Sturmlechner I, Khani F, Spitzer S, Rumpler M, Zwerina J, Karlic H, Dudakovic A, Klaushofer K, Teti A, Rucci N, Varga F, van Wijnen AJ. Thaler R, et al. Among authors: maurizi a. J Biol Chem. 2016 Mar 25;291(13):6754-71. doi: 10.1074/jbc.M115.678235. Epub 2016 Jan 12. J Biol Chem. 2016. PMID: 26757819 Free PMC article.

8

Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone.

Cappariello A, Loftus A, Muraca M, Maurizi A, Rucci N, Teti A. Cappariello A, et al. Among authors: maurizi a. J Bone Miner Res. 2018 Mar;33(3):517-533. doi: 10.1002/jbmr.3332. Epub 2017 Dec 11. J Bone Miner Res. 2018. PMID: 29091316 Free article.

9

A Complex Role for Lipocalin 2 in Bone Metabolism: Global Ablation in Mice Induces Osteopenia Caused by an Altered Energy Metabolism.

Capulli M, Ponzetti M, Maurizi A, Gemini-Piperni S, Berger T, Mak TW, Teti A, Rucci N. Capulli M, et al. Among authors: maurizi a. J Bone Miner Res. 2018 Jun;33(6):1141-1153. doi: 10.1002/jbmr.3406. Epub 2018 Mar 24. J Bone Miner Res. 2018. PMID: 29444358 Free article.

10

RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development.

Maurizi A, Capulli M, Patel R, Curle A, Rucci N, Teti A. Maurizi A, et al. Bone. 2018 May;110:343-354. doi: 10.1016/j.bone.2018.02.031. Epub 2018 Mar 6. Bone. 2018. PMID: 29501587

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page